Promise for prostatitis?
Wyllie
Michael G
MG
Urodoc Ltd., Maryland, Ridgeway Road, Herne, Kent CT6 7LN, UK. mike@urodoc.co.uk
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000726:Androgen Antagonists / Q000627:therapeutic use; D005419:Flavonoids / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D008297:Male; D008517:Phytotherapy; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011472:Prostatitis / Q000188:drug therapy*; D016896:Treatment Outcome
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D005419:Flavonoids